 | • レポートコード：QY2207C0768 • 出版社/出版日：QYResearch / 2022年7月15日 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のカタログペプチドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカタログペプチドの世界市場のxxx％を占める「純度：95％〜98％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「商業」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のカタログペプチドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのカタログペプチド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのカタログペプチド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 カタログペプチドのグローバル主要メーカーには、PolyPeptide Group、CSBio、GL Biochem (Shanghai) Ltd.、CPC Scientific、Auspep、Peptides International, Inc.、Vivitide、Applied Biological Materials (ABM) Inc、Biomatik、Bio-Synthesis Inc、Thermo Fisher Scientific、Genscript Biotech、Bachem、JPT Peptide Technologies、Advanced ChemTech、LifeTein、Eurogentec SA、Elim Biopharm Inc.、Creative Peptides、Abbiotec、NovoPro Bioscience Inc.、KareBay Biochem, Inc.、Ontores Biotechnologies Inc、Severn Biotech、Kaneka Corporation、AnaSpec、AAPPTec、Merck Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 カタログペプチド市場は、種類と用途によって区分されます。世界のカタログペプチド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度：95％〜98％、純度：98％以上 【用途別セグメント】 商業、学術研究、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - カタログペプチド製品概要 - 種類別市場（純度：95％〜98％、純度：98％以上） - 用途別市場（商業、学術研究、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のカタログペプチド販売量予測2017-2028 - 世界のカタログペプチド売上予測2017-2028 - カタログペプチドの地域別販売量 - カタログペプチドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別カタログペプチド販売量 - 主要メーカー別カタログペプチド売上 - 主要メーカー別カタログペプチド価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度：95％〜98％、純度：98％以上） - カタログペプチドの種類別販売量 - カタログペプチドの種類別売上 - カタログペプチドの種類別価格 ・用途別市場規模（商業、学術研究、その他） - カタログペプチドの用途別販売量 - カタログペプチドの用途別売上 - カタログペプチドの用途別価格 ・北米市場 - 北米のカタログペプチド市場規模（種類別、用途別） - 主要国別のカタログペプチド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのカタログペプチド市場規模（種類別、用途別） - 主要国別のカタログペプチド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のカタログペプチド市場規模（種類別、用途別） - 主要国別のカタログペプチド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のカタログペプチド市場規模（種類別、用途別） - 主要国別のカタログペプチド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのカタログペプチド市場規模（種類別、用途別） - 主要国別のカタログペプチド市場規模（トルコ、サウジアラビア） ・企業情報 PolyPeptide Group、CSBio、GL Biochem (Shanghai) Ltd.、CPC Scientific、Auspep、Peptides International, Inc.、Vivitide、Applied Biological Materials (ABM) Inc、Biomatik、Bio-Synthesis Inc、Thermo Fisher Scientific、Genscript Biotech、Bachem、JPT Peptide Technologies、Advanced ChemTech、LifeTein、Eurogentec SA、Elim Biopharm Inc.、Creative Peptides、Abbiotec、NovoPro Bioscience Inc.、KareBay Biochem, Inc.、Ontores Biotechnologies Inc、Severn Biotech、Kaneka Corporation、AnaSpec、AAPPTec、Merck Group ・産業チェーン及び販売チャネル分析 - カタログペプチドの産業チェーン分析 - カタログペプチドの原材料 - カタログペプチドの生産プロセス - カタログペプチドの販売及びマーケティング - カタログペプチドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - カタログペプチドの産業動向 - カタログペプチドのマーケットドライバー - カタログペプチドの課題 - カタログペプチドの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Catalog Peptides Market
Due to the COVID-19 pandemic, the global Catalog Peptides market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity: 95% to 98% accounting for % of the Catalog Peptides global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Commercial segment is altered to an % CAGR throughout this forecast period.
China Catalog Peptides market size is valued at US$ million in 2021, while the US and Europe Catalog Peptides are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Catalog Peptides landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Catalog Peptides include PolyPeptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific, Auspep, Peptides International, Inc., Vivitide, Applied Biological Materials (ABM) Inc and Biomatik, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Catalog Peptides capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Catalog Peptides by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Catalog Peptides Scope and Segment
Catalog Peptides market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Catalog Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity: 95% to 98%
Purity: Above 98%
Segment by Application
Commercial
Academic Research
Others
By Company
PolyPeptide Group
CSBio
GL Biochem (Shanghai) Ltd.
CPC Scientific
Auspep
Peptides International, Inc.
Vivitide
Applied Biological Materials (ABM) Inc
Biomatik
Bio-Synthesis Inc
Thermo Fisher Scientific
Genscript Biotech
Bachem
JPT Peptide Technologies
Advanced ChemTech
LifeTein
Eurogentec SA
Elim Biopharm Inc.
Creative Peptides
Abbiotec
NovoPro Bioscience Inc.
KareBay Biochem, Inc.
Ontores Biotechnologies Inc
Severn Biotech
Kaneka Corporation
AnaSpec
AAPPTec
Merck Group
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Catalog Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Catalog Peptides Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity: 95% to 98%
1.2.3 Purity: Above 98%
1.3 Market by Application
1.3.1 Global Catalog Peptides Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Catalog Peptides Production
2.1 Global Catalog Peptides Production Capacity (2017-2028)
2.2 Global Catalog Peptides Production by Region: 2017 VS 2021 VS 2028
2.3 Global Catalog Peptides Production by Region
2.3.1 Global Catalog Peptides Historic Production by Region (2017-2022)
2.3.2 Global Catalog Peptides Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Catalog Peptides Sales in Volume & Value Estimates and Forecasts
3.1 Global Catalog Peptides Sales Estimates and Forecasts 2017-2028
3.2 Global Catalog Peptides Revenue Estimates and Forecasts 2017-2028
3.3 Global Catalog Peptides Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Catalog Peptides Sales by Region
3.4.1 Global Catalog Peptides Sales by Region (2017-2022)
3.4.2 Global Sales Catalog Peptides by Region (2023-2028)
3.5 Global Catalog Peptides Revenue by Region
3.5.1 Global Catalog Peptides Revenue by Region (2017-2022)
3.5.2 Global Catalog Peptides Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Catalog Peptides Production Capacity by Manufacturers
4.2 Global Catalog Peptides Sales by Manufacturers
4.2.1 Global Catalog Peptides Sales by Manufacturers (2017-2022)
4.2.2 Global Catalog Peptides Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Catalog Peptides in 2021
4.3 Global Catalog Peptides Revenue by Manufacturers
4.3.1 Global Catalog Peptides Revenue by Manufacturers (2017-2022)
4.3.2 Global Catalog Peptides Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Catalog Peptides Revenue in 2021
4.4 Global Catalog Peptides Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Catalog Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Catalog Peptides Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Catalog Peptides Sales by Type
5.1.1 Global Catalog Peptides Historical Sales by Type (2017-2022)
5.1.2 Global Catalog Peptides Forecasted Sales by Type (2023-2028)
5.1.3 Global Catalog Peptides Sales Market Share by Type (2017-2028)
5.2 Global Catalog Peptides Revenue by Type
5.2.1 Global Catalog Peptides Historical Revenue by Type (2017-2022)
5.2.2 Global Catalog Peptides Forecasted Revenue by Type (2023-2028)
5.2.3 Global Catalog Peptides Revenue Market Share by Type (2017-2028)
5.3 Global Catalog Peptides Price by Type
5.3.1 Global Catalog Peptides Price by Type (2017-2022)
5.3.2 Global Catalog Peptides Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Catalog Peptides Sales by Application
6.1.1 Global Catalog Peptides Historical Sales by Application (2017-2022)
6.1.2 Global Catalog Peptides Forecasted Sales by Application (2023-2028)
6.1.3 Global Catalog Peptides Sales Market Share by Application (2017-2028)
6.2 Global Catalog Peptides Revenue by Application
6.2.1 Global Catalog Peptides Historical Revenue by Application (2017-2022)
6.2.2 Global Catalog Peptides Forecasted Revenue by Application (2023-2028)
6.2.3 Global Catalog Peptides Revenue Market Share by Application (2017-2028)
6.3 Global Catalog Peptides Price by Application
6.3.1 Global Catalog Peptides Price by Application (2017-2022)
6.3.2 Global Catalog Peptides Price Forecast by Application (2023-2028)
7 North America
7.1 North America Catalog Peptides Market Size by Type
7.1.1 North America Catalog Peptides Sales by Type (2017-2028)
7.1.2 North America Catalog Peptides Revenue by Type (2017-2028)
7.2 North America Catalog Peptides Market Size by Application
7.2.1 North America Catalog Peptides Sales by Application (2017-2028)
7.2.2 North America Catalog Peptides Revenue by Application (2017-2028)
7.3 North America Catalog Peptides Sales by Country
7.3.1 North America Catalog Peptides Sales by Country (2017-2028)
7.3.2 North America Catalog Peptides Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Catalog Peptides Market Size by Type
8.1.1 Europe Catalog Peptides Sales by Type (2017-2028)
8.1.2 Europe Catalog Peptides Revenue by Type (2017-2028)
8.2 Europe Catalog Peptides Market Size by Application
8.2.1 Europe Catalog Peptides Sales by Application (2017-2028)
8.2.2 Europe Catalog Peptides Revenue by Application (2017-2028)
8.3 Europe Catalog Peptides Sales by Country
8.3.1 Europe Catalog Peptides Sales by Country (2017-2028)
8.3.2 Europe Catalog Peptides Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Catalog Peptides Market Size by Type
9.1.1 Asia Pacific Catalog Peptides Sales by Type (2017-2028)
9.1.2 Asia Pacific Catalog Peptides Revenue by Type (2017-2028)
9.2 Asia Pacific Catalog Peptides Market Size by Application
9.2.1 Asia Pacific Catalog Peptides Sales by Application (2017-2028)
9.2.2 Asia Pacific Catalog Peptides Revenue by Application (2017-2028)
9.3 Asia Pacific Catalog Peptides Sales by Region
9.3.1 Asia Pacific Catalog Peptides Sales by Region (2017-2028)
9.3.2 Asia Pacific Catalog Peptides Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Catalog Peptides Market Size by Type
10.1.1 Latin America Catalog Peptides Sales by Type (2017-2028)
10.1.2 Latin America Catalog Peptides Revenue by Type (2017-2028)
10.2 Latin America Catalog Peptides Market Size by Application
10.2.1 Latin America Catalog Peptides Sales by Application (2017-2028)
10.2.2 Latin America Catalog Peptides Revenue by Application (2017-2028)
10.3 Latin America Catalog Peptides Sales by Country
10.3.1 Latin America Catalog Peptides Sales by Country (2017-2028)
10.3.2 Latin America Catalog Peptides Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Catalog Peptides Market Size by Type
11.1.1 Middle East and Africa Catalog Peptides Sales by Type (2017-2028)
11.1.2 Middle East and Africa Catalog Peptides Revenue by Type (2017-2028)
11.2 Middle East and Africa Catalog Peptides Market Size by Application
11.2.1 Middle East and Africa Catalog Peptides Sales by Application (2017-2028)
11.2.2 Middle East and Africa Catalog Peptides Revenue by Application (2017-2028)
11.3 Middle East and Africa Catalog Peptides Sales by Country
11.3.1 Middle East and Africa Catalog Peptides Sales by Country (2017-2028)
11.3.2 Middle East and Africa Catalog Peptides Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 PolyPeptide Group
12.1.1 PolyPeptide Group Corporation Information
12.1.2 PolyPeptide Group Overview
12.1.3 PolyPeptide Group Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 PolyPeptide Group Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 PolyPeptide Group Recent Developments
12.2 CSBio
12.2.1 CSBio Corporation Information
12.2.2 CSBio Overview
12.2.3 CSBio Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 CSBio Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 CSBio Recent Developments
12.3 GL Biochem (Shanghai) Ltd.
12.3.1 GL Biochem (Shanghai) Ltd. Corporation Information
12.3.2 GL Biochem (Shanghai) Ltd. Overview
12.3.3 GL Biochem (Shanghai) Ltd. Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 GL Biochem (Shanghai) Ltd. Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 GL Biochem (Shanghai) Ltd. Recent Developments
12.4 CPC Scientific
12.4.1 CPC Scientific Corporation Information
12.4.2 CPC Scientific Overview
12.4.3 CPC Scientific Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 CPC Scientific Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 CPC Scientific Recent Developments
12.5 Auspep
12.5.1 Auspep Corporation Information
12.5.2 Auspep Overview
12.5.3 Auspep Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Auspep Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Auspep Recent Developments
12.6 Peptides International, Inc.
12.6.1 Peptides International, Inc. Corporation Information
12.6.2 Peptides International, Inc. Overview
12.6.3 Peptides International, Inc. Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Peptides International, Inc. Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Peptides International, Inc. Recent Developments
12.7 Vivitide
12.7.1 Vivitide Corporation Information
12.7.2 Vivitide Overview
12.7.3 Vivitide Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Vivitide Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Vivitide Recent Developments
12.8 Applied Biological Materials (ABM) Inc
12.8.1 Applied Biological Materials (ABM) Inc Corporation Information
12.8.2 Applied Biological Materials (ABM) Inc Overview
12.8.3 Applied Biological Materials (ABM) Inc Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Applied Biological Materials (ABM) Inc Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Applied Biological Materials (ABM) Inc Recent Developments
12.9 Biomatik
12.9.1 Biomatik Corporation Information
12.9.2 Biomatik Overview
12.9.3 Biomatik Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Biomatik Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Biomatik Recent Developments
12.10 Bio-Synthesis Inc
12.10.1 Bio-Synthesis Inc Corporation Information
12.10.2 Bio-Synthesis Inc Overview
12.10.3 Bio-Synthesis Inc Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Bio-Synthesis Inc Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Bio-Synthesis Inc Recent Developments
12.11 Thermo Fisher Scientific
12.11.1 Thermo Fisher Scientific Corporation Information
12.11.2 Thermo Fisher Scientific Overview
12.11.3 Thermo Fisher Scientific Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Thermo Fisher Scientific Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Thermo Fisher Scientific Recent Developments
12.12 Genscript Biotech
12.12.1 Genscript Biotech Corporation Information
12.12.2 Genscript Biotech Overview
12.12.3 Genscript Biotech Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Genscript Biotech Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Genscript Biotech Recent Developments
12.13 Bachem
12.13.1 Bachem Corporation Information
12.13.2 Bachem Overview
12.13.3 Bachem Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Bachem Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Bachem Recent Developments
12.14 JPT Peptide Technologies
12.14.1 JPT Peptide Technologies Corporation Information
12.14.2 JPT Peptide Technologies Overview
12.14.3 JPT Peptide Technologies Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 JPT Peptide Technologies Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 JPT Peptide Technologies Recent Developments
12.15 Advanced ChemTech
12.15.1 Advanced ChemTech Corporation Information
12.15.2 Advanced ChemTech Overview
12.15.3 Advanced ChemTech Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Advanced ChemTech Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Advanced ChemTech Recent Developments
12.16 LifeTein
12.16.1 LifeTein Corporation Information
12.16.2 LifeTein Overview
12.16.3 LifeTein Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 LifeTein Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 LifeTein Recent Developments
12.17 Eurogentec SA
12.17.1 Eurogentec SA Corporation Information
12.17.2 Eurogentec SA Overview
12.17.3 Eurogentec SA Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Eurogentec SA Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Eurogentec SA Recent Developments
12.18 Elim Biopharm Inc.
12.18.1 Elim Biopharm Inc. Corporation Information
12.18.2 Elim Biopharm Inc. Overview
12.18.3 Elim Biopharm Inc. Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Elim Biopharm Inc. Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Elim Biopharm Inc. Recent Developments
12.19 Creative Peptides
12.19.1 Creative Peptides Corporation Information
12.19.2 Creative Peptides Overview
12.19.3 Creative Peptides Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 Creative Peptides Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Creative Peptides Recent Developments
12.20 Abbiotec
12.20.1 Abbiotec Corporation Information
12.20.2 Abbiotec Overview
12.20.3 Abbiotec Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 Abbiotec Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Abbiotec Recent Developments
12.21 NovoPro Bioscience Inc.
12.21.1 NovoPro Bioscience Inc. Corporation Information
12.21.2 NovoPro Bioscience Inc. Overview
12.21.3 NovoPro Bioscience Inc. Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.21.4 NovoPro Bioscience Inc. Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.21.5 NovoPro Bioscience Inc. Recent Developments
12.22 KareBay Biochem, Inc.
12.22.1 KareBay Biochem, Inc. Corporation Information
12.22.2 KareBay Biochem, Inc. Overview
12.22.3 KareBay Biochem, Inc. Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.22.4 KareBay Biochem, Inc. Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.22.5 KareBay Biochem, Inc. Recent Developments
12.23 Ontores Biotechnologies Inc
12.23.1 Ontores Biotechnologies Inc Corporation Information
12.23.2 Ontores Biotechnologies Inc Overview
12.23.3 Ontores Biotechnologies Inc Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.23.4 Ontores Biotechnologies Inc Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.23.5 Ontores Biotechnologies Inc Recent Developments
12.24 Severn Biotech
12.24.1 Severn Biotech Corporation Information
12.24.2 Severn Biotech Overview
12.24.3 Severn Biotech Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.24.4 Severn Biotech Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.24.5 Severn Biotech Recent Developments
12.25 Kaneka Corporation
12.25.1 Kaneka Corporation Corporation Information
12.25.2 Kaneka Corporation Overview
12.25.3 Kaneka Corporation Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.25.4 Kaneka Corporation Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.25.5 Kaneka Corporation Recent Developments
12.26 AnaSpec
12.26.1 AnaSpec Corporation Information
12.26.2 AnaSpec Overview
12.26.3 AnaSpec Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.26.4 AnaSpec Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.26.5 AnaSpec Recent Developments
12.27 AAPPTec
12.27.1 AAPPTec Corporation Information
12.27.2 AAPPTec Overview
12.27.3 AAPPTec Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.27.4 AAPPTec Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.27.5 AAPPTec Recent Developments
12.28 Merck Group
12.28.1 Merck Group Corporation Information
12.28.2 Merck Group Overview
12.28.3 Merck Group Catalog Peptides Sales, Price, Revenue and Gross Margin (2017-2022)
12.28.4 Merck Group Catalog Peptides Product Model Numbers, Pictures, Descriptions and Specifications
12.28.5 Merck Group Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Catalog Peptides Industry Chain Analysis
13.2 Catalog Peptides Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Catalog Peptides Production Mode & Process
13.4 Catalog Peptides Sales and Marketing
13.4.1 Catalog Peptides Sales Channels
13.4.2 Catalog Peptides Distributors
13.5 Catalog Peptides Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Catalog Peptides Industry Trends
14.2 Catalog Peptides Market Drivers
14.3 Catalog Peptides Market Challenges
14.4 Catalog Peptides Market Restraints
15 Key Finding in The Global Catalog Peptides Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer